Abstract
COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Coronaviruses
Title:Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions
Volume: 2 Issue: 11
Author(s): Ram Kumar Dhaked*
Affiliation:
- Biotechnology Division, Defence Research & Development Establishment, Ministry of Defence, Govt. of India, Jhansi Road, Gwalior - 474002,India
Keywords: COVID-19, coronavirus (2019-n CoV), drug interventions, vaccine, immune system, non-drug/vaccine
Abstract: COVID-19 pandemic affected over 227 countries with more than 147 million infections that claimed 31.22 lacs lives. The first case of the pandemic was reported from China in Dec, 2019 showing pneumonia like symptoms that turned out to be the novel strain of coronavirus (2019-n- CoV). The WHO declared 2019-nCoV infection as the Public Health Emergency of International Concern and the disease named coronavirus disease (COVID-19). The infection curve of the pandemic has been flattened in many countries around the world, but the effective new antiviral drugs or vaccine has not yet developed. So far, we are saved by non-pharmaceutical interventions like handwashing, social distancing, quarantine, masks and health-care workers by personal protective equipments. Now the question arises that what we do if no effective drug or vaccine emerges? In the absence of effective drug/vaccines, pandemic has to be fought at community level not at hospitals. For such emergent situations, we need a ‘Plan B’ based non-vaccine/drug interventions.
Export Options
About this article
Cite this article as:
Dhaked Kumar Ram *, Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions, Coronaviruses 2021; 2 (11) : e310821191744 . https://dx.doi.org/10.2174/2666796702666210223155638
DOI https://dx.doi.org/10.2174/2666796702666210223155638 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry Perspectives and Prospects on mRNA Vaccine Development for COVID-19
Current Medicinal Chemistry The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking
Combinatorial Chemistry & High Throughput Screening Virtual Screening, Molecular Docking and <i>In silico</i> ADME-Tox Analysis for Identification of Potential Main Protease (Mpro) Enzyme Inhibitors
Anti-Infective Agents The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic
Current Pharmaceutical Design Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review
Coronaviruses Pilot Randomised Controlled Trial to Test Effectiveness of Facemasks in Preventing Influenza-like Illness Transmission among Australian Hajj Pilgrims in 2011
Infectious Disorders - Drug Targets High Throughput Screening for Bioactive Components from Traditional Chinese Medicine
Combinatorial Chemistry & High Throughput Screening The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Bioinformatics-Based Characterization of Proteins Related to SARS-CoV- 2 Using the Polarity Index Method<sup>®</sup> (PIM<sup>®</sup>) and Intrinsic Disorder Predisposition
Current Proteomics In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV
Medicinal Chemistry Research and Patents on Coronavirus and COVID-19: A Review
Recent Patents on Nanotechnology COVID-19: Structure, Replication and its Global Scenario
Current Nanomedicine Molecular Characterization of SARS-CoV-2
Current Molecular Medicine Characterization of Proteins from Putative Human DNA and RNA Viruses
Current Proteomics Correlations and Hierarchical Clustering Investigation Between Weather and SARS-CoV-2
Recent Advances in Computer Science and Communications Misinformation About COVID-19 and Confidential Information Leakage: Impacts on the Psychological Well-being of Indians
Current Psychiatry Research and Reviews Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Anxiety, Insomnia and Body Mass Index Scores in Italian Nurses Engaged in the Care of COVID-19 Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Discovery of Potent Anti-SARS-CoV MPro Inhibitors
Current Computer-Aided Drug Design